Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

ATNMATNM
12 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in ACTINIUM PHARMACEUTICALS INC

WELLS FARGO & COMPANY/MN holds 19,800 shares of ATNM (ACTINIUM PHARMACEUTICALS INC), worth $19,404 as of 2026-Q2.

Current Value

$19,404

Current Shares

19,800

Total Value Change

-$43,981

Total Shares Change

+9,093

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
19,800
0.0%
$19,4040.0%$0.98
0
2026-Q1
Unchanged
19,800
0.0%
$19,7070.0%$1.11
0
2025-Q4
Unchanged
19,800
0.0%
$26,9280.0%$1.41
0
2025-Q3
Increased
19,800
+259.5%
$31,6800.0%$1.62
22
2025-Q2
Decreased
5,508
-72.9%
$7,7110.0%$1.42
0
2025-Q1
Increased
20,326
+1.7%
$32,7250.0%$1.81
14
2024-Q4
Increased
19,994
+37.3%
$25,1920.0%$1.17
17
2024-Q3
Decreased
14,559
-2.5%
$27,3710.0%$1.80
0
2024-Q2
Increased
14,924
+9.2%
$110,4380.0%$7.40
16
2024-Q1
Increased
13,667
+9.8%
$107,0130.0%$7.83
16
2023-Q4
Increased
12,443
+16.2%
$63,2100.0%$5.08
16
2023-Q3
New
10,707
-
$63,3850.0%$5.92
32

Other major holders of ATNM: BlackRock Finance, Inc., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used